Efficacy of DC-CIK Immunotherapy Combined with Chemotherapy on Locally Advanced Gastric Cancer

Table 2

Comparison of tumor response of patients in the two studied groups.

Parameters	DC-CIK group n = 53	Control group n = 53	value
Complete response (CR)	2 (3.8%)	0 (0%)
Partial response (PR)	23 (43.4%)	22 (41.5%)
Stable disease (SD)	12 (22.6%)	5 (9.4%)
Progressive disease (PD)	16 (30.2%)	26 (49.1%)
ORR (CR + PR)	25 (47.2%)	22 (41.5%)	0.696
DCR (CR + PR + SD)	37 (69.8%)	27 (50.9%)	0.033

Notes. DC-CIK: dendritic cell-cytokine-induced killer cells; ORR: overall response rate; DCR: disease control rate.